Australia Stock Exchange release from CYNATA THERAPEUT : DSMB Recommends Continuation of Cynata's MEND Trial
07/10/2021 23:23
Australia Stock Exchange release from CYNATA THERAPEUT CYP.AX : DSMB Recommends Continuation of Cynata's MEND Trial
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million